Mayo Clinic

London Exchange

bioMérieux invests £70M in Oxford Nanopore to advance nanopore-based IVD solutions
ByNNR October 19, 2023October 19, 2023

LONDON, UK: bioMérieux SA, a world leader in the field of in vitro diagnostics (“IVD”), has announced that it is making an immediate £70M investment in Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of nanopore-based…

Read More bioMérieux invests £70M in Oxford Nanopore to advance nanopore-based IVD solutions
London Exchange

Imaging Biometrics and Mayo Clinic enter into an agreement to develop IB Trax
ByNNR November 9, 2020October 24, 2023

LONDON: Imaging Biometrics LLC (IB), has entered into an agreement with Mayo Clinic to develop a brain lesion tracking platform, IB Trax, a news release said. The collaboration’s objective is the development of an innovative AI technology to track metastatic…

Read More Imaging Biometrics and Mayo Clinic enter into an agreement to develop IB Trax